Hari Kannan, MD
Psychiatry · Sioux Falls, SDNPI 1447222906
Payments from drug & device makers
Across 1,381 payments — averaging $661.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$579K
- Axsome Therapeutics, Inc.$230K
- Avanir Pharmaceuticals, Inc.$101K
- Vanda Pharmaceuticals Inc.$3K
- Jazz Pharmaceuticals Inc.$391
- Acadia Pharmaceuticals Inc$38
- plus $16 from 1 others
What the payments were for
- Consulting fees$54,9386%
- Speaking & faculty fees$630,16569%
- Travel & lodging$208,74123%
- Food & beverage$19,1582%
- Education$3910%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 973 | $579,108 |
| Axsome Therapeutics, Inc. | 279 | $229,731 |
| Avanir Pharmaceuticals, Inc. | 117 | $100,851 |
| Vanda Pharmaceuticals Inc. | 2 | $3,257 |
| Jazz Pharmaceuticals Inc. | 7 | $391 |
| Acadia Pharmaceuticals Inc | 2 | $38 |
| Alfasigma USA, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$913,393 in reported general payments places this provider in the 95th percentile of 79 psychiatry providers in South Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AplenzinBupropion Hbr | 12 | $30,496 |
| EdluarZolpidem Tartrate | 13 | $6,253 |
| Memantine Hcl ErMemantine Hcl | 25 | $4,344 |
| Vilazodone Hcl | 19 | $2,629 |
| Rivastigmine | 12 | $2,094 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 24 | $1,981 |
| Armodafinil | 23 | $1,557 |
| Bupropion XlBupropion Hcl | 51 | $1,510 |
| Escitalopram Oxalate | 40 | $1,090 |
| Zolpidem Tartrate ErZolpidem Tartrate | 25 | $768 |
| Clonazepam | 53 | $574 |
| Quetiapine Fumarate | 40 | $560 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 44 | $358 |
| Valproic AcidValproic Acid (As Sodium Salt) | 26 | $298 |
| Sertraline Hcl | 17 | $179 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Sioux Falls
- James ChiuSioux Falls$1.7M
- Rajesh SinghSioux Falls$393K
- Anthony VacaSioux Falls$15K
- Mackenzie MertzSioux Falls$4K
- Georgiana NussSioux Falls$4K
- Sandra Peynado RojasSioux Falls$3K
- David ErmerSioux Falls$3K
- Clay PavlisSioux Falls$2K
- William FullerSioux Falls$2K
- Xiaofan LiSioux Falls$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.